Use of cloprostenol, fluprostenol and their analogues to treat glaucoma and ocular hypertension
CA 2129287 C · Owner: Alcon Laboratories, Inc. · Inventors: Zinke, Paul W.; Klimko, Peter G.; Sallee, Verney L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed is the use of cloprostenol, fluprostenol their analogues and their pharmaceutically acceptable salts and esters for the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic compositions comprising said compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 2, 1994 and granted May 14, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 2, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 2, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.